Comprehensive Diagnostic & Therapeutic Reference Profile
Also known as: Dwarfism, Short-limbed dwarfism, FGFR3-related skeletal dysplasia.
Achondroplasia is the most common form of disproportionate short-stature skeletal dysplasia. It is a genetic disorder characterized by impaired endochondral ossification, leading to shortened proximal limbs, macrocephaly, and distinct craniofacial features.
Achondroplasia is caused by a gain-of-function mutation in the FGFR3 gene on chromosome 4p16.
The mutation leads to the constitutive activation of Fibroblast Growth Factor Receptor 3, which negatively regulates chondrocyte proliferation and differentiation in the growth plate. This impairs longitudinal bone growth, primarily affecting long bones.
The prevalence is approximately 1 in 15,000 to 40,000 live births. It affects both genders equally and occurs across all ethnic groups.
Advanced paternal age is a primary risk factor for de novo mutations.
A. Early Symptoms
Inspection reveals rhizomelic shortening, midface hypoplasia, and a depressed nasal bridge. Palpation may show kyphosis or limited extension at the elbows.
A. Clinical Assessment: Based on physical phenotype.
B. Laboratory Testing: Generally not required for diagnosis.
C. Imaging Studies: Skeletal survey.
D. Functional Tests: Polysomnography.
E. Biopsy Findings: Not indicated.
F. Genetic Testing: FGFR3 molecular testing.
G. Differential Diagnosis: Hypochondroplasia, thanatophoric dysplasia.
Test Name: FGFR3 Mutation Analysis
Type: Blood Test
Purpose: Confirm diagnosis
Expected Findings: Pathogenic variant
Interpretation: Confirms achondroplasia
Skeletal Survey: Identifies characteristic findings (e.g., narrowed interpedicular distance in the lumbar spine, squared iliac wings).
Hypochondroplasia (milder phenotype), Thanatophoric dysplasia (lethal), Pseudoachondroplasia.
Spinal stenosis, hydrocephalus, mid-ear infections, obesity.
A. Lifestyle Modifications: Ergonomic adjustments, weight management.
B. Preventive Measures: Sleep apnea monitoring.
C. Medical Treatment: Vosoritide (C-type natriuretic peptide analog).
D. Surgical Treatment: Decompression for stenosis, limb lengthening (controversial).
E. Interventional Procedures: Ventriculoperitoneal shunt for hydrocephalus.
F. Rehabilitation: Physical/occupational therapy.
G. Emergency Management: Neurosurgical evaluation for cord compression.
Life expectancy is slightly reduced compared to the general population, largely due to respiratory/neurological complications.
Genetic counseling for prospective parents.
The following homeopathic remedies have been historically indicated for symptoms associated with Achondroplasia. Selection should be based on individualized symptom totality and constitutional assessment.
This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.
Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, and identify reference range variances related to Achondroplasia.
Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, identify reference range variances, and generate a plain-English explanation of your disease risks.
Browse our full library of 200+ medical and pathology calculators.
π Browse All CalculatorsSpeak with our specialists for a customized treatment protocol for this condition.
π Request ConsultationThis clinical reference is for educational purposes only. It is not a substitute for professional medical diagnosis or treatment. Always consult a licensed healthcare practitioner.